FDA Approved: FOSRENOL — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved Fosrenol (lanthanum carbonate) through Takeda's original NDA to treat hyperphosphatemia in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• FOSRENOL (lanthanum carbonate)

Snippet

ORIG AP for FOSRENOL (LANTHANUM CARBONATE)